← All Sponsors
SPONSOR

Amicus Therapeutics

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Fabry Disease
NCT06904261 Phase 3
Recruiting

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

Fabry Disease
United States, Belgium, Germany View Trial →
NCT06906367
Recruiting

A Study of Patients With Fabry Disease (US Specific)

Fabry Disease
United States View Trial →